A complex relation between levels of adult hippocampal neurogenesis and expression of the immature neuron marker doublecortin

Hippocampus. 2023 Oct;33(10):1075-1093. doi: 10.1002/hipo.23568. Epub 2023 Jul 8.

Abstract

We investigated the mechanisms underlying the effects of the antidepressant fluoxetine on behavior and adult hippocampal neurogenesis (AHN). After confirming our earlier report that the signaling molecule β-arrestin-2 (β-Arr2) is required for the antidepressant-like effects of fluoxetine, we found that the effects of fluoxetine on proliferation of neural progenitors and survival of adult-born granule cells are absent in the β-Arr2 knockout (KO) mice. To our surprise, fluoxetine induced a dramatic upregulation of the number of doublecortin (DCX)-expressing cells in the β-Arr2 KO mice, indicating that this marker can be increased even though AHN is not. We discovered two other conditions where a complex relationship occurs between the number of DCX-expressing cells compared to levels of AHN: a chronic antidepressant model where DCX is upregulated and an inflammation model where DCX is downregulated. We concluded that assessing the number of DCX-expressing cells alone to quantify levels of AHN can be complex and that caution should be applied when label retention techniques are unavailable.

Keywords: adult hippocampal neurogenesis; antidepressant; doublecortin; inflammation; β-arrestin-2.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Doublecortin Protein*
  • Fluoxetine* / pharmacology
  • Hippocampus / physiology
  • Mice
  • Neurogenesis / physiology
  • Neurons

Substances

  • Antidepressive Agents
  • Doublecortin Protein
  • Fluoxetine
  • Dcx protein, mouse